DK Life Science Co., Ltd.

₩1,860As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:303810Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE 3.81%
Medical Instruments & Supplies
Beta (5Y) —
PE TTM 11.95
TSR TTM (50.60%)
Mkt cap ₩59.49B
ROIC 4.93%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩2,077
11.68%
(68.70%)
Hold 6|0|1|3|0
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
26.62
25.65
25.05
25.52
23.79%
13.63%
0.67%
(8.16%)
Revenue₩B
3.241
3.287
3.430
3.349
14.28%
9.42%
12.17%
3.52%
Peers (US$43.86M)
Cap (US$)
PE
237.3M
11.10x
108.6M
9.067x
83.66M
5.789x
Capital
TTM
5Y
10Y
Leveragex
1.607
0.863
0.842
EBIT/Intx
0.077
0.787
0.788
Own earn%
65.99
(42.21)
(39.67)
Sh yield%
31.28
6.55
12.49
Owners
Insiders/Inst%
8.04
52.70
Short interest%
4.09
SBC / revenue%
0.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
21–25
$1 testx
—
Incr. ROIC%
3